Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
24,445 total articles
Altimmune, Inc. has initiated enrollment in the PERFORMA global Phase 3 clinical trial to evaluate the efficacy and safety of its lead drug candidate, pemvidutide, in patients with metabolic dysfunction-associated steatohepatitis (MASH) and moderate to advanced fibrosis. Building on positive Phase 2b IMPACT trial data demonstrating significant MASH…
KellyOCG, the outsourcing and consulting division of Kelly Services, has been named a global and U.S. leader in Everest Group's 2026 Recruitment Process Outsourcing (RPO) Services PEAK Matrix. This accolade reflects KellyOCG's integrated and scalable talent acquisition services supported by AI-powered technology such as its Sevayo platform and cons…
VirTra, Inc., a global provider of use-of-force and firearms training simulators, will hold its second quarter 2026 earnings conference call on August 13, 2026, to discuss financial results for the period ended June 30, 2026. The company will issue a press release prior to the call, followed by a management presentation and Q&A session. This event …
GSI Technology, an innovator in Associative Processing Unit technology for AI and high-performance computing, announced its participation in the Needham Virtual Semiconductor & SemiCap Conference on August 19-20, 2026. Company executives will hold one-on-one meetings with institutional investors during the event to discuss their scalable, low-power…
Freedom Metals Acquisition Corp., a blank check company focused on mergers in the mining and critical minerals industry, announced that its Class A Ordinary Shares and Warrants will begin separate trading on Nasdaq starting August 4, 2026. Previously trading as combined units, shareholders can now trade shares under ticker FDMM and warrants under F…
Powerus, through its subsidiary Tandem Defense, has secured a competitively awarded indefinite-delivery/indefinite-quantity contract from the U.S. Air Force with a ceiling value of up to $90 million through mid-2028. The contract covers Group 1 aerial-denial unmanned aircraft systems, including equipment, training, and field service support. This a…
Taysha Gene Therapies and Catalent have expanded their partnership to include commercial manufacturing support for Taysha's investigational gene therapy TSHA-102 targeting Rett syndrome. The agreement ensures long-term commercial manufacturing capacity at Catalent's FDA-licensed facility, supporting a potential U.S. launch pending FDA approval. Thi…
Kayne Anderson Energy Infrastructure Fund, Inc. (NYSE: KYN) announced a monthly distribution of $0.09 per share payable on August 31, 2026. The fund focuses on energy infrastructure investments, aiming to provide high after-tax returns with regular cash distributions, which are subject to board approval and company financial covenants.
Nexera Technologies Ltd announced a letter of intent with Nebo Holdings Limited to become the exclusive worldwide reseller and distributor of Nebo's Preempt OSINT darknet intelligence software, targeting operators of data centers with threat detection services. The agreement, pending a technical proof of concept and due diligence, aims to expand Ne…
Helus Pharma announces the appointment of Michael Halstead as CEO to lead the company through critical late-stage clinical development and commercialization phases. Halstead brings 25 years of experience from Intra-Cellular Therapies, including a successful track record in drug development, launch, and commercialization. The company is advancing HL…
Tyson Foods, Inc. announced the availability of its third quarter 2026 financial results via an earnings release on its Investor Relations website. The company will host a conference call and webcast to discuss the earnings, with the report also filed with the SEC on Form 8-K.
Curium US Holdings is acquiring Lantheus Holdings in an $8 billion deal that will consolidate complementary radiopharmaceutical portfolios and global manufacturing and commercial platforms. The transaction offers Lantheus shareholders $102.50 per share in cash at closing plus up to $12.00 per share in contingent value rights tied to commercial mile…
Navigator Holdings Ltd. announced the signing of a $121.8 million senior secured loan facility to finance two newbuild ammonia-fueled liquefied ammonia carriers currently under construction in China. The financing supports the company's ammonia growth strategy, enabling delivery of the vessels in 2028 with a six-year post-delivery tenor and competi…
ARS Pharmaceuticals, a biopharmaceutical company focused on treatments for allergic reactions and anaphylaxis, announced a conference call and webcast on August 13, 2026, to outline updated strategic priorities and report their Q2 2026 financial results. The company is commercially offering neffy®, an epinephrine nasal spray approved for emergency …
Medicus Pharma Ltd. appoints Dr. Faisal Mehmud, Chief Medical Officer and Co-Chairman of Antev Limited, as CEO of its UK subsidiary effective August 30, 2026. This leadership move aims to unify scientific, clinical, regulatory, and operational efforts as the company advances development of Teverelix®, targeting advanced prostate cancer, urinary ret…
Hub Cyber Security Ltd. announced it has regained compliance with Nasdaq's Market Value of Listed Securities requirement, closing a previous deficiency. This milestone highlights the company's progress in its strategic transformation to improve liquidity, governance, and operational efficiency while exploring growth opportunities.
Hydrofarm Holdings Group, Inc. has completed the sale of its subsidiary Aurora Peat Products to Raven Holdings LLC for $16 million, applying proceeds to reduce debt and simplify operations. The company will maintain a supply agreement with Aurora Peat and plans to focus on scaling its logistics services platform through a new initiative named Proje…
Zevra Therapeutics announced the publication of a four-year longitudinal real-world study assessing its FDA-approved drug MIPLYFFA® (arimoclomol) in treating Niemann-Pick disease type C (NPC). The study, covering 109 U.S. patients including adults, showed stable disease severity scores and confirmed the drug's known safety profile. This data streng…
BridgeBio Pharma, a biopharmaceutical company specializing in genetic condition medicines, will release its second quarter 2026 financial results and provide business updates after market close on August 10, 2026. The company will also host a conference call and webcast to discuss financials and program progress.
Solowin Holdings' subsidiary AX Coin Bahrain has achieved a significant milestone by obtaining formal Sharia certification for its AXBHD stablecoin. This certification, conducted by the Shariyah Review Bureau licensed by the Central Bank of Bahrain, marks AXBHD as the first central bank-regulated stablecoin to receive such recognition. The certific…
Autolus Therapeutics reported preliminary Q2 2026 AUCATZYL net product revenue of approximately $45 million with a gross margin improvement to around 35%. The company raised 2026 sales guidance to $140–$150 million, up from $120–$135 million. Autolus secured a $250 million five-year credit facility with Perceptive Advisors, including $75 million fu…
OwlTing Group reported a 107.6% increase in payment volume and a 109.5% rise in transaction count for its digital currency-based cross-border payment platform, OwlPay Harbor, in July 2026 compared to June. The company continues to expand enterprise clients and transaction activity across multiple global markets, leveraging its regulatory licenses a…
Avista Corp. reported a net income increase to $35 million in Q2 2026 from $14 million in Q2 2025, driven by improved investment performance and regulatory impacts. The company confirmed its 2026 non-GAAP utility earnings guidance of $2.52 to $2.72 per diluted share and anticipates long-term utility earnings growth of 4-6%. Capital expenditures rem…
X-energy, a US-based developer of advanced nuclear reactors, announced an agreement with SGL Carbon to double the production capacity of nuclear-grade graphite (NBG-18), a critical material for X-energy's Xe-100 high-temperature gas-cooled reactors. The investment supports a commercial pipeline exceeding 11 GW and enhances supply chain resilience f…
Smartkem, Inc. announced a definitive all-stock merger agreement with Ferrox Critical Minerals, valuing Ferrox at $125 million. The merger positions Smartkem as a vertically integrated public electronics company, now sourcing critical minerals from Ferrox's Tivani project in South Africa, supporting steel, pigment, aerospace, and energy storage sup…
